Related references
Note: Only part of the references are listed.Effect of low dose naloxone on the immune system function of a patient undergoing video-assisted thoracoscopic resection of lung cancer with sufentanil controlled analgesia - a randomized controlled trial
Yun Lin et al.
BMC ANESTHESIOLOGY (2019)
Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer
Samual Francis et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong et al.
LANCET ONCOLOGY (2018)
Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States
Matthew P. Smeltzer et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)
Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the US National Cancer Data Base
Raymond U. Osarogiagbon et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)
Juliane Rieber et al.
LUNG CANCER (2016)
Impact of Intraoperative Blood Loss on Long-Term Survival after Lung Cancer Resection
Haruhiko Nakamura et al.
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
Impact of Adjuvant Treatment for Microscopic Residual Disease After Non-Small Cell Lung Cancer Surgery
Jacquelyn G. Hancock et al.
ANNALS OF THORACIC SURGERY (2015)
Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer
Meixiang Zhou et al.
BMC CANCER (2015)
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
Karen Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer
Elyn H. Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer
Jaehyeon Park et al.
RADIATION ONCOLOGY JOURNAL (2014)
Postoperative Radiotherapy for Incompletely Resected Non-small Cell Lung Cancer: Clinical Outcomes and Prognostic Value of the Histological Subtype
Takayuki Ohguri et al.
JOURNAL OF RADIATION RESEARCH (2012)
Microscopic Residual Disease After Resection for Lung Cancer: A Multifaceted but Poor Factor of Prognosis
Marc Riquet et al.
ANNALS OF THORACIC SURGERY (2010)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The impact of residual tumor morphology on prognosis, recurrence, and fistula formation after lung cancer resection
Takeshi Kawaguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Residual disease at the bronchial stump after curative resection for lung cancer
Jan Wind et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database
Brian E. Lally et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation
SJ Maygarden et al.
MODERN PATHOLOGY (2004)
Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer
HS Hofmann et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2002)
Share Paper
